UK gene therapeutics firm files US IPO

Sam Kerr

July 20, 2020 12:15 pm

The stock market continues to surge after the 4th of July Holiday during the Coronavirus Pandemic in New York City. The Dow Jones Industrial Average rose 460 points today. (NYC) | SMXRF/Starmax/PA Images

Freeline Theraputics, the UK gene therapeutics company, has filed to list in the US on the Nasdaq exchange, continuing the trend of biotech companies seeking to raise capital in the equity capital markets.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOs Health and Biotech Equity UK United States Americas Europe North America EMEA SRI

SK

Sam Kerr